相关实验视频
Updated: Mar 18, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.7K
概括
癌症免疫疗法依赖于识别新抗原. 这项研究表明瘤可以失去这些新抗原,但T细胞适应,强调需要广泛的T细胞反应来防止抵抗.
科学领域:
- 免疫学
- 癌症学
- 遗传学
背景情况:
- 由DNA损伤产生的新抗原是癌症免疫疗法的关键目标,如T细胞检查点阻断和采用T细胞疗法.
- 瘤抗原性可以通过T细胞压力改变,可能导致在临床前模型中识别的突变抗原的丧失.
- 随着时间的推移,新抗原特异性T细胞反应及其点的稳定性仍然在很大程度上未被描述.
研究的目的:
- 在接受采用性T细胞移植的晚期黑色素瘤患者中研究新抗原特异性T细胞反应和它们识别的抗原的稳定性.
- 在新抗原识别和潜在的免疫逃生机制的背景下,了解瘤细胞和T细胞之间的动态相互作用.
主要方法:
- 在两个患有第四阶段黑色素瘤的患者中分析了新抗原特异性T细胞反应及其识别的抗原.
- 评估与T细胞识别的新抗原相关的瘤细胞群的变化,包括基因表达和突变性等位基因丧失.
- 对瘤透性淋巴细胞中对新抗原损失的反应的评估.
主要成果:
- 在研究患者中,T细胞识别的新抗原被选择性地从瘤细胞群中丢失.
- 通过基因表达的减少或突变等位基因的丧失发生了新抗原损失.
- 新抗原的丧失与瘤透性淋巴细胞中新抗原特异性T细胞反应的发展有关.
结论:
- T细胞介导一种新抗原免疫编辑形式,与癌细胞进行动态相互作用.
- 瘤细胞可以通过失去目标新抗原来逃避T细胞的识别.
- 治疗策略应旨在诱导广泛的新抗原特异性T细胞反应,以克服瘤抵抗力并防止免疫逃逸.
相关概念视频
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Antigens Involved in Adaptive Immunity
1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K

